Patent 11747297 was granted and assigned to Siemens Healthcare Diagnostics Inc. on September, 2023 by the United States Patent and Trademark Office.
There is provided a chloride selective membrane including an epoxide-based matrix reacted with a stoichiometric amount of an amino compound and an activator such that the epoxide-based matrix comprises a number of quaternary ammonium groups.